Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE

BACKGROUND: The Natural History and Neuroprotection in Parkinson Plus Syndromes (NNIPPS) study was a large phase III randomized placebo-controlled trial of riluzole in Progressive Supranuclear Palsy (PSP, n = 362) and Multiple System Atrophy (MSA, n = 398). To assess disease severity and progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Payan, Christine A. M., Viallet, François, Landwehrmeyer, Bernhard G., Bonnet, Anne-Marie, Borg, Michel, Durif, Franck, Lacomblez, Lucette, Bloch, Frédéric, Verny, Marc, Fermanian, Jacques, Agid, Yves, Ludolph, Albert C., Leigh, Peter N., Bensimon, Gilbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150329/
https://www.ncbi.nlm.nih.gov/pubmed/21829612
http://dx.doi.org/10.1371/journal.pone.0022293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150329/
https://www.ncbi.nlm.nih.gov/pubmed/21829612
http://dx.doi.org/10.1371/journal.pone.0022293

Ejemplares similares